• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Model Number 03R89-48
Medical Device Problem Code Data Problem (3196)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/28/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.
 
Event or Problem Description
The customer reported that for approximately 85 patient samples managed jointly by abbott and roche, when all the samples have been tested by the abbott analyzer and produced results, the ams added a new rule to set the default value of 1 for the roche classified assays (s_roche).This default is not shielded and will also be transmitted to the lis, meaning all results that are classified s_roche will be sent to the lis as 1.There was no reported impact to patient management.
 
Additional Manufacturer Narrative
The complaint investigation indicated that the root cause of the issue was an incorrect configuration of the of the product performed by the aliniq ams engineer.The issue happened because the results for the test ¿s_roche¿ were not prevented being sent to the lis through the aliniq ams configuration.As a resolution, the configuration of the flag ¿send to lis after validation¿ on aliniq ams was modified to avoid the transmission of the test results to the lis after validation.Additionally, a configuration change was also implemented on the lis side, to discard ¿s_roche¿ results when received from the aliniq ams.As a consequence, ¿s_roche¿ results, if still received from aliniq ams, wouldn¿t be displayed any more on the lis interface.No adverse trend was identified for the customer's issue.A review of the labeling addresses the customer¿s issue.Based on all available information and abbott diagnostics' complaint investigation, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINIQ AMS
Common Device Name
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT  00144
MDR Report Key12180358
Report Number3004032053-2021-00001
Device Sequence Number11469490
Product Code JQP
UDI-Device Identifier00380740189914
UDI-Public00380740189914
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number03R89-48
Device Catalogue Number03R89-48
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer 06/28/2021
Supplement Date Received by Manufacturer08/02/2021
Initial Report FDA Received Date07/16/2021
Supplement Report FDA Received Date08/03/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-